Evidence map›Paper›PMID 35760871›Full record

ReviewNature metabolism2022

Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo.

Michael P Murphy, Hülya Bayir, Vsevolod Belousov, Christopher J Chang, Kelvin J A Davies, Michael J Davies, Tobias P Dick, Toren Finkel, Henry J Forman, Yvonne Janssen-Heininger and 15 more

Open access · bronzeAbstract readReviewConsensus Statement
In one paragraph

Review in Nature metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 601 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
601citing papers in PubMed, 4 pooled it
95.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

601 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,208 citations in OpenAlex.

  1. Pooled it
  2. An Updated Understanding of Human Embryonic Fragmentation.Reproductive sciences (Thousand Oaks, Calif.) · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. CHCliScience · 2026
    Article
  11. Article
  12. Article
  13. Experimental and therapeutic medicine · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Modulation of Hepatic Cholesterol-Related Pathways byMolecules (Basel, Switzerland) · 2026
    Article
  20. Review

541 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 12 countries.

Michael P MurphyMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. mpm@mrc-mbu.cam.ac.uk.ORCID http://orcid.org/0000-0003-1115-9618
Hülya BayirDepartment of Critical Care Medicine, Safar Center for Resuscitation Research, Children's Neuroscience Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Vsevolod BelousovFederal Center of Brain Research and Neurotechnologies, Moscow, Russian Federation.
Christopher J ChangUniversity of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0001-5732-9497
Kelvin J A DaviesGerontology, Molecular & Computational Biology, and Biochemistry & Molecular Medicine, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-7790-3003
Michael J DaviesDepartment of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-5196-6919
Tobias P DickGerman Cancer Research Center, DKFZ-ZMBH Alliance and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Toren FinkelUniversity of Pittsburgh, Pittsburgh, PA, USA.
Henry J FormanGerontology, Molecular & Computational Biology, and Biochemistry & Molecular Medicine, University of Southern California, Los Angeles, CA, USA.
Yvonne Janssen-HeiningerInstitute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London, London, UK.
David GemsUniversity of Vermont, Burlington, VT, USA.
Valerian E KaganDepartment of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-7245-1885
Balaraman KalyanaramanMedical College of Wisconsin, Milwaukee, WI, USA.
Nils-Göran LarssonDivision of Molecular Metabolism, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Ginger L MilneDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Thomas NyströmUniversity of Gothenburg, Gothenburg, Sweden.
Henrik E PoulsenUniversity Hospital Copenhagen, Copenhagen, Denmark.
Rafael RadiUniversidad de la República, Montevideo, Uruguay.
Holly Van RemmenOklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Paul T SchumackerNorthwestern University, Evanston, IL, USA.
Paul J ThornalleyQatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.ORCID http://orcid.org/0000-0001-7659-443X
Shinya ToyokuniNagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-5757-1109
Christine C WinterbournDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Huiyong YinShanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0000-0001-7049-1560
Barry HalliwellDepartment of Biochemistry and Life Sciences Institute Neurobiogy Programme, National University of Singapore, Singapore, Singapore. bchbh@nus.edu.sg.ORCID http://orcid.org/0000-0002-3560-7123
University of Pittsburgh · USUniversity of Southern California · USCopenhagen University Hospital · DKGerman Cancer Research Center · DEHamad bin Khalifa University · QAKarolinska Institutet · SEMedical College of Wisconsin · USMRC Unit for Lifelong Health and Ageing · GBNagoya University · JPNational University of Singapore · SGNorthwestern University · USOklahoma Medical Research Foundation · USResearch Center of Neurology · RUShanghai Institute of Nutrition and Health · CNUniversidad de la República de Uruguay · UYUniversity of California, Berkeley · USUniversity of Cambridge · GBUniversity of Copenhagen · DKUniversity of Gothenburg · SEUniversity of Otago · NZ

Funding

Regulation of Cardiolin Byosynthesis in Epithelial InjuryP01HL114453 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MALLAMPALLI, RAMA K · 2014 to 2023
$21.3M
Molecular Imaging Probes To Study Redox BiologyR01GM079465 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Christopher J. Chang · 2006 to 2026
$7.8M
Mapping Lipid Oxidation in Traumatic Brain Injury by Mass Spectrometric ImagingR01NS076511 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Hülya Bayir, Valerian E Kagan · 2012 to 2026
$6.8M
S-glutathionylation chemistry in fibrotic lung remodelingR35HL135828 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2017 to 2023
$6.5M
OXYGEN RADICAL TOXICITY AND RED CELL PROTEIN DEGRADATIONR01ES003598 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DAVIES, KELVIN J. A. · 1988 to 2017
$5.7M
USC Geroscience Training in the Biology of AgingT32AG052374 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Sean P CURRAN · 2016 to 2026
$5.3M
Chemical Probes to Study Formaldehyde BiologyR01ES028096 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Christopher J. Chang · 2017 to 2026
$4.1M
Lipids and Myeloid Cell Function in CancerR01CA165065 · NCI · WISTAR INSTITUTE · PI KAGAN, VALERIAN E, MONTANER, LUIS J · 2012 to 2022
$3.8M
Therapeutic targeting MDSC-mediated immune suppression in cancerR01CA266342 · NCI · WISTAR INSTITUTE · PI Valerian E Kagan, Yulia Nefedova · 2022 to 2026
$3.5M
Oxidative Lipidomics in Pediatric Traumatic Brain InjuryR01NS061817 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAYIR, HÜLYA · 2008 to 2018
$3.3M
Protein-Oxidized Phospholipid Interactions Determine Epithelial Cell Fate and Asthma Control  R01AI145406 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sally E Wenzel · 2020 to 2026
$2.9M
Chemical Probes to Study Methionine Redox BiologyR01GM139245 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Christopher J. Chang · 2020 to 2026
$2.9M
BLRD VA IK6 BX005234Medical Research Council MC_UU_00015/3NCI NIH HHS R01 CA165065NCI NIH HHS R01 CA266342NHLBI NIH HHS P01 HL114453NHLBI NIH HHS R35 HL135828NIAID NIH HHS R01 AI145406NIAID NIH HHS U01 AI156923NIAID NIH HHS U01 AI156924NIA NIH HHS T32 AG052374NIEHS NIH HHS R01 ES003598NIEHS NIH HHS R01 ES028096NIEHS NIH HHS R56 ES003598NIGMS NIH HHS R01 GM079465NIGMS NIH HHS R01 GM139245NINDS NIH HHS R01 NS061817NINDS NIH HHS R01 NS076511NINDS NIH HHS R01 NS117000NINDS NIH HHS R37 NS061817Wellcome TrustWellcome Trust 220257/Z/20/Z
6 · The paper itself

Abstract

Multiple roles of reactive oxygen species (ROS) and their consequences for health and disease are emerging throughout biological sciences. This development has led researchers unfamiliar with the complexities of ROS and their reactions to employ commercial kits and probes to measure ROS and oxidative damage inappropriately, treating ROS (a generic abbreviation) as if it were a discrete molecular entity. Unfortunately, the application and interpretation of these measurements are fraught with challenges and limitations. This can lead to misleading claims entering the literature and impeding progress, despite a well-established body of knowledge on how best to assess individual ROS, their reactions, role as signalling molecules and the oxidative damage that they can cause. In this consensus statement we illuminate problems that can arise with many commonly used approaches for measurement of ROS and oxidative damage, and propose guidelines for best practice. We hope that these strategies will be useful to those who find their research requiring assessment of ROS, oxidative damage and redox signalling in cells and in vivo.

Indexed as

AntioxidantsOxidative StressOxidation-ReductionReactive Oxygen SpeciesSignal TransductionAntioxidantsReactive Oxygen Species

Identifiers

PMID35760871
PMCPMC9711940
OpenAlexW4283701282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.